Status | Study |
Terminated |
Study Name: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies Condition: Mixed Lineage Acute Leukemia Acute Myeloid Leukemia Date: 2015-04-14 Interventions: Drug: Bortezomib Bortezomib wi |
Recruiting |
Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Condition: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut Date: 2014-08-18 Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation |
Completed |
Study Name: Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome Condition: Acute Myeloid Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) Date: 2014-07-30 Interventions: Drug: Selinexor Given orally o |
Recruiting |
Study Name: A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL) Condition: Leukemia Date: 2014-05-08 Interventions: Drug: Clofarabine |
Recruiting |
Study Name: Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) Condition: Leukemia Date: 2014-04-14 Interventions: Drug: Cladribine |
Recruiting |
Study Name: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes Condition: Acute Biphenotypic Leukemia de Novo Myelodysplastic Syndrome Date: 2014-01-22 Interventions: Drug: Cladribine Given IV |
Recruiting |
Study Name: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention Condition: Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia Date: 2013-09-24 Interventions: Drug: tacrolimus Tacrolimus 0. |
Recruiting |
Study Name: S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia Condition: Acute Leukemias of Ambiguous Lineage B-cell Adult Acute Lymphob Date: 2013-08-15 Interventions: Drug: cyclophosphamide Given I |
Terminated |
Study Name: Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia Condition: Relapsed or Refractory Acute Lymphoblastic Leukemia Relapsed or Refractory Lymphoblastic Lym Date: 2013-06-05 Interventions: Drug: MLN9708 Drug: Vincristine |
Active, not recruiting |
Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children Condition: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut Date: 2013-05-15 Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation |